Baidu
map

流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用专家共识(2019版)

2019-06-30 中国儿科相关医学专家组(统称) 中华儿科杂志.2019.57(6):424-428.

流式细胞术检测淋巴细胞亚群被越来越多地应用于儿科临床,对疾病的诊断、治疗具有重要作用。然而,由于其结果判读的复杂性,尚未能被临床工作者充分认识。“流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用共识”于2016年首次发表,经普及推广对临床工作起到了很好的帮助。随着技术的发展,为适应医学发展和临床应用的需要,再次组织专家进行更新。

中文标题:

流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用专家共识(2019版)

发布日期:

2019-06-30

简要介绍:

流式细胞术检测淋巴细胞亚群被越来越多地应用于儿科临床,对疾病的诊断、治疗具有重要作用。然而,由于其结果判读的复杂性,尚未能被临床工作者充分认识。“流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用共识”于2016年首次发表,经普及推广对临床工作起到了很好的帮助。随着技术的发展,为适应医学发展和临床应用的需要,再次组织专家进行更新。
 
拓展指南:淋巴细胞相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用专家共识(2019版))] GetToolGuiderByIdResponse(projectId=1, id=b11451c001e653fd, title=流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用专家共识(2019版), enTitle=, guiderFrom=中华儿科杂志.2019.57(6):424-428., authorId=null, author=, summary=流式细胞术检测淋巴细胞亚群被越来越多地应用于儿科临床,对疾病的诊断、治疗具有重要作用。然而,由于其结果判读的复杂性,尚未能被临床工作者充分认识。“流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用共识”于2016年首次发表,经普及推广对临床工作起到了很好的帮助。随着技术的发展,为适应医学发展和临床应用的需要,再次组织专家进行更新。 , cover=, journalId=null, articlesId=null, associationId=924, associationName=中国儿科相关医学专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Sun Jun 30 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>流式细胞术检测淋巴细胞亚群被越来越多地应用于儿科临床,对疾病的诊断、治疗具有重要作用。然而,由于其结果判读的复杂性,尚未能被临床工作者充分认识。“流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用共识”于2016年首次发表,经普及推广对临床工作起到了很好的帮助。随着技术的发展,为适应医学发展和临床应用的需要,再次组织专家进行更新。</div> <div> </div>拓展指南:<strong>与<font color=red>淋巴细胞</font>相关指南:</strong><br><ul><li><a href="//m.sandwebs.com/guideline/show_article.do?id=ac2f71c001ea355e" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V5)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V5)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=373c61c001ea29f3" title="NCCN临床实践指南:急性淋巴细胞白血病(2019.V2)" target=_blank>NCCN临床实践指南:急性淋巴细胞白血病(2019.V2)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=3c1e31c001e299e8" title="NCCN临床实践指南:急性淋巴细胞白血病(2019.V1)" target=_blank>NCCN临床实践指南:急性淋巴细胞白血病(2019.V1)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=fec3a1c001e211bb" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V4)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V4)</a></li> <li><a href="//m.sandwebs.com/guideline/show_article.do?id=0f3f71c001e090c9" title="NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V3)" target=_blank>NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2019.V3)</a></li> 更多信息请点击:<a href="//m.sandwebs.com/guideline/list.do?q=%E6%B7%8B%E5%B7%B4%E7%BB%86%E8%83%9E" target=_blank>有关淋巴细胞更多指南</a></ul>, tagList=[TagDto(tagId=70530, tagName=:), TagDto(tagId=6890, tagName=流式细胞术), TagDto(tagId=92533, tagName=外周血淋巴细胞亚群)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=18245, appHits=205, showAppHits=60, pcHits=15721, showPcHits=3579, likes=69, shares=9, comments=4, approvalStatus=1, publishedTime=Wed Jul 24 20:57:41 CST 2019, publishedTimeString=2019-06-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Jul 24 20:57:41 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 22:32:27 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用专家共识(2019版))])
流式细胞术分析外周血淋巴细胞亚群在儿科的临床应用专家共识(2019版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051968, encodeId=b3de1051968e9, content=很受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 14:48:40 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051939, encodeId=8c9d105193982, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:43:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051929, encodeId=6469105192926, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:30:06 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976446, encodeId=39a09e6446a4, content=学习,很好的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/176341868a1e467481b3126085dda0a6/4c0bd20baa1b47b5b25fa88cffe06a9c.jpg, createdBy=7dfc5532913, createdName=艾迪迪, createdTime=Thu Jun 24 08:55:29 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-09-16 H8888888

    很受益

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051968, encodeId=b3de1051968e9, content=很受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 14:48:40 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051939, encodeId=8c9d105193982, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:43:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051929, encodeId=6469105192926, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:30:06 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976446, encodeId=39a09e6446a4, content=学习,很好的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/176341868a1e467481b3126085dda0a6/4c0bd20baa1b47b5b25fa88cffe06a9c.jpg, createdBy=7dfc5532913, createdName=艾迪迪, createdTime=Thu Jun 24 08:55:29 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-09-16 ms2000001041372596

    很好 已学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1051968, encodeId=b3de1051968e9, content=很受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 14:48:40 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051939, encodeId=8c9d105193982, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:43:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051929, encodeId=6469105192926, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:30:06 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976446, encodeId=39a09e6446a4, content=学习,很好的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/176341868a1e467481b3126085dda0a6/4c0bd20baa1b47b5b25fa88cffe06a9c.jpg, createdBy=7dfc5532913, createdName=艾迪迪, createdTime=Thu Jun 24 08:55:29 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-09-16 ms2000001041372596

    很好 已学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1051968, encodeId=b3de1051968e9, content=很受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Thu Sep 16 14:48:40 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051939, encodeId=8c9d105193982, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:43:44 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051929, encodeId=6469105192926, content=很好 已学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=ms2000001041372596, createdTime=Thu Sep 16 12:30:06 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=976446, encodeId=39a09e6446a4, content=学习,很好的平台, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210624/176341868a1e467481b3126085dda0a6/4c0bd20baa1b47b5b25fa88cffe06a9c.jpg, createdBy=7dfc5532913, createdName=艾迪迪, createdTime=Thu Jun 24 08:55:29 CST 2021, time=2021-06-24, status=1, ipAttribution=)]
    2021-06-24 艾迪迪

    学习,很好的平台

    0

Baidu
map
Baidu
map
Baidu
map